Beta-Thalassemia Minor in Pregnant Women Screened in Rural India
Researchers studied the prevalence of beta-thalassemia minor in pregnant women in a rural region of India.
Researchers studied the prevalence of beta-thalassemia minor in pregnant women in a rural region of India.
Extended decitabine produced a similar overall survival rate as standard chemotherapy, but decitabine had a better safety profile.
Overall, there was no improvement in complete response or survival outcomes among patients who received bortezomib.
A large proportion of patients with relapsed/refractory diffuse large B-cell lymphoma do not undergo repeat biopsy, a study suggests.
Male survivors of classical Hodgkin lymphoma had lower childbearing rates if they received BEACOPP rather than ABVD.
Researchers characterized the abundance and impacts of extracellular vesicles associated with recombinant factor VIIa treatment in patients with hemophilia.
A single-center study sought to determine the effects of SARS-CoV-2 vaccination in patients with myeloproliferative neoplasms.
The likelihood of recovery of major molecular response after resuming TKI therapy at reduced doses was 86%.
The combination produced an overall response rate of 99%, and the 5-year remission rate was 76%.
Researchers sought to determine whether parsaclisib could be an effective treatment that improves hemoglobin levels in patients with autoimmune hemolytic anemia.